Document is current
Any future updates will be listed below
-
Authors
,
Semler, Elisa
Anderl-Straub, Sarah
Uttner, Ingo
Diehl-Schmid, Janine
Danek, Adrian
Einsiedler, Beate
Fassbender, Klaus
Fliessbach, Klaus
Huppertz, Hans-Jürgen
Jahn, Holger
Kornhuber, Johannes
Landwehrmeyer, Bernhard
Lauer, Martin
Muche, Rainer
Prudlo, Johannes
Schneider, Anja
Schroeter, Matthias L.
Ludolph, Albert C.
Otto, Markus
-
Funding
Funding for this research was provided by:
Ministerium für Wissenschaft, Forschung und Kultur (FTLDc O1GI1007A)
Baden-Württemberg Stiftung (D.3830)
EU Joint Programme – Neurodegenerative Disease Research (SOPHIA)
EU Joint Programme – Neurodegenerative Disease Research (BiomarkAPD)
EU Joint Programme – Neurodegenerative Disease Research (PreFrontAls)
EU (Fairpark II)
Boehringer Ingelheim Ulm University BioCenter (D.5009)
- License Information
-
More Information
Article History
Received: 4 November 2017
Accepted: 22 January 2018
First Online: 25 April 2018
Ethics approval and consent to participate
: The study was approved by the local Ethics Committee at the central study center at University of Ulm (proposal number 39/11, 8 March 2011) and by the Ethics Committees at each individual recruiting site and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. Written informed consent was obtained from each patient, participant, caregiver, or legal representative prior to inclusion in the study.
: All authors have approved the manuscript for submission and gave consent for publication.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
